Csenge Advisory Group increased its stake in shares of Eli Lilly and Company (NYSE:LLY – Free Report) by 19.3% in the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 4,130 shares of the company’s stock after buying an additional 669 shares during the period. Csenge Advisory Group’s […]